Segment Information (Tables)

9 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization were as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(In thousands)	2022			2021			2022			2021
Revenue:
Medical Device	$	17,528		$	16,755		$	52,889		$	60,858
In Vitro Diagnostics		7,326			7,118			21,074			20,307
Total revenue	$	24,854		$	23,873		$	73,963		$	81,165
Operating (loss) income:
Medical Device	$	(7,308	)	$	(2,491	)	$	(16,712	)	$	5,480
In Vitro Diagnostics		3,387			3,378			10,262			10,407
Total segment operating (loss) income		(3,921	)		887			(6,450	)		15,887
Corporate		(3,222	)		(3,271	)		(9,034	)		(8,695	)
Total operating (loss) income	$	(7,143	)	$	(2,384	)	$	(15,484	)	$	7,192
Depreciation and amortization:
Medical Device	$	2,020		$	1,631		$	6,347		$	5,004
In Vitro Diagnostics		88			121			260			314
Corporate		98			92			295			292
Total depreciation and amortization	$	2,206		$	1,844		$	6,902		$	5,610